Corona: Germany and Europe Could Fall Short on Vaccine Supplies - DER SPIEGEL
►https://www.spiegel.de/international/europe/the-planning-disaster-germany-and-europe-could-fall-short-on-vaccine-supplie
Scientists estimate that 60 to 70 percent of Germany’s population would need to be vaccinated in order to stop the virus. That would require 100 to 120 million doses because, with one exception, all the vaccines currently available have to be administered in two doses before they deliver immunity.
The EU has ordered a total of 1.3 billion doses from six different manufacturers. Germany is entitled to 18.6 percent of those doses in a distribution mechanism calculated according to its share of the EU population. That amounts to around 250 million doses. But the number is misleading.
Currently, the only deliveries that are certain are those from German-American consortium BioNTech/Pfizer and the American biotech company Moderna.
BioNTech, whose vaccine is to be approved by the EU on Dec. 21, will be able to supply around 45 million doses to Germany in the first half of the year, according to current estimates. Moderna, whose vaccine is due to be authorized for use in Europe on Jan. 6, could supply around 15 million doses. Together, that’s a total of 60 million doses, which is far too little.